Expression of the CD11c antigen in B-cell chronic lymphoproliferative disorders

Leukemia and Lymphoma

Volumn 37, Issue 1-2, 2000, Pages 145-149

  Marotta, Giuseppe ^a   Raspadori, Donatella ^b   Sestigiani, Chiara ^b   Scalia, Giulia ^b   Bigazzi, Catia ^b   Lauria, Francesco ^b  

^a Ospedale A Sclavo   (Italy)

^b NONE

Author keywords

B cell chronic lymphoproliferative disorders; 2 integrin CD11c

Indexed keywords

GLYCOPROTEIN P 15095;

ANTIGEN EXPRESSION; ARTICLE; B CELL LEUKEMIA; CHRONIC DISEASE; CHRONIC LYMPHATIC LEUKEMIA; HAIRY CELL LEUKEMIA; HUMAN; HUMAN CELL; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROLYMPHOCYTIC LEUKEMIA;

EID: 0034048309     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190009057637     Document Type: Article

References (23)

1. Springer TA. (1990) Adhesion receptors in the immune system Nature, 346, 425-434.
2. Kishimoto TK, Larson RS, Corbi AL, Dustin ML, Staunton DE, Springer TA. (1989) The leukocyte integrins. Adv Immunol, 46, 149-182.
3. Larson RS, Springer TA. (1990) Structure and function of leukocyte integrins. Immunol Rev, 114, 181-217.
4. Keizer GD, Borst J, Visser W, Schwarting R, De Vries JE, Figdor CG. (1987) Membrane glycoprotein p 150,95 of human cytotoxic T cell clones is involved in conjugate formation with target cells. J Immunol, 138, 3130-3136.
5. Postigo AA, Corbi AL, Sanchez-Madrid F, de Landazuri MO. (1991) Regulated expression and function of CD11c/CD18 integrin on human B lymphocytes. Relation between attachment to fibrinogen and triggering of proliferation through CD11c/CD18. J Exp Med, 17, 1313-1322.
6. Springer TA, Miller LJ, Anderson DC. (1986) P150, 95 the third member of the Mac-1, LFA-1 human leukocyte adhesion glycoprotein family. J Immunol, 136, 240-245.
7. Lecoanet-Hencchoz S, Gauchat JF, Aubry JP, Graber P, Life P, Paul-Eugen N, Ferrua B, Corbi AL, Dugas B, Plater-Zyberk C, Bonnefoy JY. (1995) CD23 regulates monocyte activation through a novel interaction with the adhesion molecules CD11b-CD18 and CD11c-CD18. Immunity, 3, 119-125.
8. Schwarting R, Stein H, Wang CY. (1985) The monoclonal antibodies (αLeu-14) and αS-HCL 3 (αLeu-M5) allow the diagnosis of hairy cell leukemia. Blood, 65, 974-983.
9. Wormsley SB, Baird SM, Gadol N, Rai KR, Sobol RE. (1990) Characteristics of CD11c+ CD5+ chronic B-cell leukemias and the identification of novel pripheral blood B-cell subsets with chronic limphoid leukemia immunophenotypes. Blood, 76, 123-130.
10. Hanson CA, Gribbin TE, Schnitzer B, Schlegelmilch JA, Mitchell BS, Stoolman LM. (1990) CD11c (Leu-M5) expression characterizes a B-cell chronic lymphoproliferative disorder with features of both chronic lymphocytic leukemia and hairy cell leukemia. Blood, 76, 2360-2367.
11. Tassies D, Montserrat E, Villamor N, Rozman C. (1991) CD11c positive B-chronic lymphocytic leukemia. Blood, 78, 1893.
12. Palutke M, Tabaczka P, Gingrich D. (1992) CD11c expression in chronic lymphocytic leukemia. Blood, 80, 2685.
13. Molica S, Dattilo A., Mannela A. (1993) CD11c expression in B-cell chronic lymphocytic leukemia. Blood, 81, 2466.
14. Newman RA, Peterson B, Davey FR, Brabyn C, Collins H, Brunetto VL, Duggan DB, Weiss RB, Royston I, Millard FE, Miller AA, Bloomfield CD. (1993) Phenotypic markers and BCL-1 gene rearrangements in B-cell chronic lymphocytic leukemia: A Cancer and Leukemia Group B study. Blood, 82, 1239-1246.
15. Eisterer W, Hilbe W, Stauder R, Bechter O, Fend F, Thaler J. (1996) An aggressive subtype of B-CLL is characterized by strong CD44 expression and lack of CD11c. Br J Haematol; 93: 661-669.
16. Marotta G, Bucalossi A, Galieni P, Bigazzi C, Nuti S, Valensin PE, Bocchia M, Lauria F. (1998) CD4+/CD45RA+ "naive" T cells and immunological response to influenza virus vaccine in B-cell chronic lymphocytic leukaemia patients. Acta Haematol, 99, 18-21.
17. Lauria F, Raspadori D, Ventura MA, Rondelli D, Testoni N, Tosi P, Michieli M, Damiani D, Malta MR, Tura S. (1995) The presence of lymphoid-associated antigens in adult acute myeloid leukemia is devoid of prognostic relevance. Stem Cell, 13, 428.
18. Siegel S. (1956) Non parametric statistics for the behavioral sciences. New York, Mc Graw-Hill.
19. Defrance TJ, Aubry JP, Rousset F, Vanbervliet B, Bonnefoy JY, Arai N, Takebe Y, Yokota T, Lee F, Arai K, de Vries JE, Banchereau J. (1987) Human recombinant interleukin 4 induces Fcε receptors (CD23) on normal human lymphocytes. J Exp Med, 165, 1459-1464.
20. Spiegelberg HL. (1981) Lymphocytes bearing Fc receptors for IgE. Immunol Rev, 56, 199-218.
21. Melewictz FM, Plummer JM, Spiegelberg HL. (1982) Comparison of the Fc receptors for IgE on human lymphocytes and monocytes. J Immunol, 129, 563-571.
22. Capron M, Jouault T, Prin L, Joseph M, Ameisen JC, Butterworth AE, Papin JP, Kusnierz JP, Capron A. (1986) Functional study of a monoclonal antibody to Ige Fc receptor (Fc epsilon RII) of eosinophils, platelets and macrophages. J Exp Med, 164, 72-79.
23. Aderka D, Maor Y, Novick D, Engelmann H, Kahn Y, Levo Y, Wallach D, Revel M. (1993) Interleukin-6 inhibits the proliferation of B.chronic lymphocytic leukemia cells that is induced by tumor necrosis factor -α or -β. Blood, 81, 2076-2084.